Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
Not yet recruiting · NCT07438860 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Not yet recruiting | Phase 1 | 2026-10-06 | NCT07438860 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tiffany Hodges | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Premier Health Neuroscience Institute | Dayton | United States | 1 |
| University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center | Cleveland | United States | 11 |